Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open13.760 | Close13.640 |
Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | 0.030 | 0.1200 | ||||
REV | 48.380M | 60.249M | 11.869M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
DVAX | Dynavax Technologies | -0.66% | 1.8B |
IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
ZNTL | Zentalis Pharma | -3.93% | 1.5B |
MRTX | Mirati Therapeutics | 12.33% | 2.9B |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
There is no dividend information for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.